Media Pack
News

Current Edition

Volume 16 Issue 2
 
Editorial Archive

Quality-of-life Improvements for Heart Health in Scarce Treatment Settings

When medical circumstances are severe and treatment options are limited in number or effectiveness, being able to help patients improve their quality of life (QOL) t...
19 April 2024 Editorial Archive | Volume 16 Issue 1 circumstances | effectiveness
Continue Reading →
Editorial Archive

A Reflection on the European Regulatory Framework

Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively bureaucratic, and challenging to navigat...
19 April 2024 Editorial Archive | Volume 16 Issue 1 approval | challenging
Continue Reading →
Editorial Archive

Feasibility Assessments: What Investigators Need to Know

The feasibility of clinical trial involves a thorough assessment of the potential and practicality of conducting a particular trial within a specified geographic are...
19 April 2024 Editorial Archive | Volume 16 Issue 1 Assessments | clinical
Continue Reading →
Editorial Archive

Five Trends Shaping the Trial Master File

The trial master file is integral to demonstrating that a clinical trial has been conducted in accordance with good clinical practice (GCP). The sponsor must therefo...
19 April 2024 Editorial Archive | Volume 16 Issue 1 clinical | conducted
Continue Reading →
Editorial Archive

Generative AI Drives Efficient Regulatory Processes

As regulatory Agencies around the world continue to refine and update their requirements, artificial intelligence (AI) can help Life Sciences companies increase thei...
19 April 2024 Editorial Archive | Volume 16 Issue 1 accepted | AI
Continue Reading →
Editorial Archive

Green Miracles: Cannabis and Kratom’s Potential for Healing and The Industry in Malaysia

Global Cannabis market size was valued at USD 14154.75 million in 2023 and is expected to expand at a CAGR of 17.17% during the forecast period, reaching USD 36619.4...
19 April 2024 Editorial Archive | Volume 16 Issue 1 cannabis | diversify
Continue Reading →
Editorial Archive

Conducting Clinical Trials in the Parallel Virtual Universe

Quantitative systems pharmacology (QSP) and physiologically based pharmacokinetic (PBPK) modelling can be employed to create a parallel virtual workflow throughout d...
19 April 2024 Editorial Archive | Volume 16 Issue 1 clinical | Conducting
Continue Reading →
Editorial Archive

Advancing Research and Development of Multi-indication and Combination Therapies for Obesity

Obesity is commonly defined as excess fat accumulation that puts someone at a higher risk for adverse health outcomes.1 The simplicity of this definition can be misl...
19 April 2024 Editorial Archive | Volume 16 Issue 1 accumulation | advancing
Continue Reading →
Editorial Archive

Defining Success in Rare Disease Paediatric Trials

Rare diseases are often chronic conditions that begin to manifest during childhood.1 The effects of disease change everything from direct consequences of having the ...
19 April 2024 Editorial Archive | Volume 16 Issue 1 childhood | chronic
Continue Reading →
Editorial Archive

Cell and Gene Therapies are set to Revolutionise Healthcare: Here’s How

The first chemotherapy drugs were discovered by mistake – during World War II – when humans were accidentally exposed to mustard gas. At that time, the only other tr...
19 April 2024 Editorial Archive | Volume 16 Issue 1 cancer | cell
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte